James Dennewill
Förmögenhet: 3 M $ per 2026-08-31
Förmögenhet: 3 M $ per 2026-08-31
James Dennewill is the Chief Operating Officer at SpyGlass Pharma, Inc. since 2021, with employment at the company starting in 2019.
Formerly, Mr. Dennewill was the Chief Operating Officer at Cianna Medical, Inc. Education includes an undergraduate degree from The California State University and an MBA from Yale School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SPYGLASS PHARMA, INC. 0,29 % | 2026-02-05 | 96 022 ( 0,29 % ) | 3 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| SPYGLASS PHARMA, INC. | Verksamhetschef | 2021-10-01 |
| Företag | Position | Slut |
|---|---|---|
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women | Verksamhetschef | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women | Health Technology |
Yale School of Management
Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpyGlass Pharma Inc
SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån